| Name | Title | Contact Details |
|---|---|---|
JoAnna Nicholson |
Chief Legal Officer | Profile |
bioVIGIL headquartered in Las Vegas, Nevada, is a leading provider of healthcare infection control and disease mitigation solutions that enhance the patient care environment improving patient safety, healthcare quality, and hospital bottom lines.
Rothenberger USA is a Rockford, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Biotechnology Business Consultants is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Groups360™️ was founded in 2014 with the goal of simplifying and transforming the ways meetings are booked. The company`s search engine, GroupSync™️, using its proprietary matching algorithms designed specifically for meeting planners, has helped place thousands of events at the right venue, saving planners time and money. GroupSync`s price predictor tool delivers improved transparency, reducing time and effort required to book meetings for both the hotel and the planner. Groups360`s management team has decades of experience in the meetings and events industry and provides the right mix of technology and experienced advisors. Using GroupSync, planners can search more than 200,000 properties in 225 countries and territories.
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.